Cargando…

Bioprinting with human stem cell-laden alginate-gelatin bioink and bioactive glass for tissue engineering

Three-dimensional (3D) bioprinting technologies have shown great potential in the fabrication of 3D models for different human tissues. Stem cells are an attractive cell source in tissue engineering as they can be directed by material and environmental cues to differentiate into multiple cell types...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolan, Krishna C. R., Semon, Julie A., Bromet, Bradley, Day, Delbert E., Leu, Ming C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310267/
https://www.ncbi.nlm.nih.gov/pubmed/32596547
http://dx.doi.org/10.18063/ijb.v5i2.2.204
_version_ 1783549338751860736
author Kolan, Krishna C. R.
Semon, Julie A.
Bromet, Bradley
Day, Delbert E.
Leu, Ming C.
author_facet Kolan, Krishna C. R.
Semon, Julie A.
Bromet, Bradley
Day, Delbert E.
Leu, Ming C.
author_sort Kolan, Krishna C. R.
collection PubMed
description Three-dimensional (3D) bioprinting technologies have shown great potential in the fabrication of 3D models for different human tissues. Stem cells are an attractive cell source in tissue engineering as they can be directed by material and environmental cues to differentiate into multiple cell types for tissue repair and regeneration. In this study, we investigate the viability of human adipose-derived mesenchymal stem cells (ASCs) in alginate-gelatin (Alg-Gel) hydrogel bioprinted with or without bioactive glass. Highly angiogenic borate bioactive glass (13-93B3) in 50 wt% is added to polycaprolactone (PCL) to fabricate scaffolds using a solvent-based extrusion 3D bioprinting technique. The fabricated scaffolds with 12 × 12 × 1 mm(3) in overall dimensions are physically characterized, and the glass dissolution from PCL/glass composite over a period of 28 days is studied. Alg-Gel composite hydrogel is used as a bioink to suspend ASCs, and scaffolds are then bioprinted in different configurations: Bioink only, PCL+bioink, and PCL/glass+bioink, to investigate ASC viability. The results indicate the feasibility of the solvent-based bioprinting process to fabricate 3D cellularized scaffolds with more than 80% viability on day 0. The decrease in viability after 7 days due to glass concentration and static culture conditions is discussed. The feasibility of modifying Alg-Gel with 13-93B3 glass for bioprinting is also investigated, and the results are discussed.
format Online
Article
Text
id pubmed-7310267
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Whioce Publishing Pte. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73102672020-06-25 Bioprinting with human stem cell-laden alginate-gelatin bioink and bioactive glass for tissue engineering Kolan, Krishna C. R. Semon, Julie A. Bromet, Bradley Day, Delbert E. Leu, Ming C. Int J Bioprint Research Article Three-dimensional (3D) bioprinting technologies have shown great potential in the fabrication of 3D models for different human tissues. Stem cells are an attractive cell source in tissue engineering as they can be directed by material and environmental cues to differentiate into multiple cell types for tissue repair and regeneration. In this study, we investigate the viability of human adipose-derived mesenchymal stem cells (ASCs) in alginate-gelatin (Alg-Gel) hydrogel bioprinted with or without bioactive glass. Highly angiogenic borate bioactive glass (13-93B3) in 50 wt% is added to polycaprolactone (PCL) to fabricate scaffolds using a solvent-based extrusion 3D bioprinting technique. The fabricated scaffolds with 12 × 12 × 1 mm(3) in overall dimensions are physically characterized, and the glass dissolution from PCL/glass composite over a period of 28 days is studied. Alg-Gel composite hydrogel is used as a bioink to suspend ASCs, and scaffolds are then bioprinted in different configurations: Bioink only, PCL+bioink, and PCL/glass+bioink, to investigate ASC viability. The results indicate the feasibility of the solvent-based bioprinting process to fabricate 3D cellularized scaffolds with more than 80% viability on day 0. The decrease in viability after 7 days due to glass concentration and static culture conditions is discussed. The feasibility of modifying Alg-Gel with 13-93B3 glass for bioprinting is also investigated, and the results are discussed. Whioce Publishing Pte. Ltd. 2019-07-12 /pmc/articles/PMC7310267/ /pubmed/32596547 http://dx.doi.org/10.18063/ijb.v5i2.2.204 Text en Copyright: © 2019, Whioce Publishing Pte. Ltd. http://creativecommons.org/licenses/cc-by-nc/4.0/ This is an open-access article distributed under the terms of the Attribution-NonCommercial 4.0 International 4.0 (CC BY-NC 4.0), which permits all non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited.
spellingShingle Research Article
Kolan, Krishna C. R.
Semon, Julie A.
Bromet, Bradley
Day, Delbert E.
Leu, Ming C.
Bioprinting with human stem cell-laden alginate-gelatin bioink and bioactive glass for tissue engineering
title Bioprinting with human stem cell-laden alginate-gelatin bioink and bioactive glass for tissue engineering
title_full Bioprinting with human stem cell-laden alginate-gelatin bioink and bioactive glass for tissue engineering
title_fullStr Bioprinting with human stem cell-laden alginate-gelatin bioink and bioactive glass for tissue engineering
title_full_unstemmed Bioprinting with human stem cell-laden alginate-gelatin bioink and bioactive glass for tissue engineering
title_short Bioprinting with human stem cell-laden alginate-gelatin bioink and bioactive glass for tissue engineering
title_sort bioprinting with human stem cell-laden alginate-gelatin bioink and bioactive glass for tissue engineering
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310267/
https://www.ncbi.nlm.nih.gov/pubmed/32596547
http://dx.doi.org/10.18063/ijb.v5i2.2.204
work_keys_str_mv AT kolankrishnacr bioprintingwithhumanstemcellladenalginategelatinbioinkandbioactiveglassfortissueengineering
AT semonjuliea bioprintingwithhumanstemcellladenalginategelatinbioinkandbioactiveglassfortissueengineering
AT brometbradley bioprintingwithhumanstemcellladenalginategelatinbioinkandbioactiveglassfortissueengineering
AT daydelberte bioprintingwithhumanstemcellladenalginategelatinbioinkandbioactiveglassfortissueengineering
AT leumingc bioprintingwithhumanstemcellladenalginategelatinbioinkandbioactiveglassfortissueengineering